- Report
- January 2025
- 175 Pages
Global
From €3970EUR$4,490USD£3,425GBP
The Panic Attack Drug market is a subset of the Anxiety Drug market, which is composed of pharmaceuticals used to treat anxiety disorders. These drugs are typically prescribed to treat panic attacks, which are sudden episodes of intense fear or discomfort that can cause physical symptoms such as a racing heart, sweating, and difficulty breathing. Commonly prescribed Panic Attack Drugs include benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), and tricyclic antidepressants. These drugs work by altering the levels of certain neurotransmitters in the brain, such as serotonin and dopamine, which can help reduce the symptoms of anxiety.
Some of the major companies in the Panic Attack Drug market include Pfizer, GlaxoSmithKline, Eli Lilly, and AstraZeneca. These companies produce a variety of drugs used to treat panic attacks, including benzodiazepines, SSRIs, and tricyclic antidepressants. Additionally, there are a number of smaller companies that produce generic versions of these drugs, which are often cheaper than the brand-name versions. Show Less Read more